These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25245378)

  • 1. Nanotechnology and antioxidant therapy: an emerging approach for neurodegenerative diseases.
    Fernandes C; Oliveira C; Benfeito S; Soares P; Garrido J; Borges F
    Curr Med Chem; 2014; 21(38):4311-27. PubMed ID: 25245378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective.
    Ratnam DV; Ankola DD; Bhardwaj V; Sahana DK; Kumar MN
    J Control Release; 2006 Jul; 113(3):189-207. PubMed ID: 16790290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria and neurodegenerative diseases: the promising role of nanotechnology in targeted drug delivery.
    Pezzini I; Mattoli V; Ciofani G
    Expert Opin Drug Deliv; 2017 Apr; 14(4):513-523. PubMed ID: 27467010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology for neurodegenerative disorders.
    Re F; Gregori M; Masserini M
    Nanomedicine; 2012 Sep; 8 Suppl 1():S51-8. PubMed ID: 22640910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promising future of nano-antioxidant therapy against environmental pollutants induced-toxicities.
    Eftekhari A; Dizaj SM; Chodari L; Sunar S; Hasanzadeh A; Ahmadian E; Hasanzadeh M
    Biomed Pharmacother; 2018 Jul; 103():1018-1027. PubMed ID: 29710659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-delivery systems for encapsulation of dietary polyphenols: An experimental approach for neurodegenerative diseases and brain tumors.
    Squillaro T; Cimini A; Peluso G; Giordano A; Melone MAB
    Biochem Pharmacol; 2018 Aug; 154():303-317. PubMed ID: 29803506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology for neurodegenerative disorders.
    Re F; Gregori M; Masserini M
    Maturitas; 2012 Sep; 73(1):45-51. PubMed ID: 22261367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the neuroprotective potential of rosmarinic acid and its association with nanotechnology-based delivery systems: A novel approach to treating neurodegenerative disorders.
    Fachel FNS; Schuh RS; Veras KS; Bassani VL; Koester LS; Henriques AT; Braganhol E; Teixeira HF
    Neurochem Int; 2019 Jan; 122():47-58. PubMed ID: 30439384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of nanotechnology in modulating oxidative stress: an overview.
    Bharali DJ; Mousa SA
    Methods Mol Biol; 2013; 1028():289-92. PubMed ID: 23740128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery aspects of antioxidants in diabetes management.
    Duvvuri LS; Katiyar S; Kumar A; Khan W
    Expert Opin Drug Deliv; 2015 May; 12(5):827-44. PubMed ID: 25582375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.
    Pehlivan SB
    Pharm Res; 2013 Oct; 30(10):2499-511. PubMed ID: 23959851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine in the ROS-mediated pathophysiology: Applications and clinical advances.
    Nash KM; Ahmed S
    Nanomedicine; 2015 Nov; 11(8):2033-40. PubMed ID: 26255114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Natural Product-Based Oral Nanomedicines for Stroke Prevention.
    Mutoh T; Mutoh T; Taki Y; Ishikawa T
    J Med Food; 2016 Jun; 19(6):521-7. PubMed ID: 27136062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-antioxidants: An emerging strategy for intervention against neurodegenerative conditions.
    Sandhir R; Yadav A; Sunkaria A; Singhal N
    Neurochem Int; 2015 Oct; 89():209-26. PubMed ID: 26315960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology-empowered therapeutics targeting neurodegenerative diseases.
    Wang Z; Gonzalez KM; Cordova LE; Lu J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1907. PubMed ID: 37248794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic functions of antioxidant nanoparticles for longevity and medicine.
    Narayanan KB; Park HH
    Adv Colloid Interface Sci; 2013 Dec; 201-202():30-42. PubMed ID: 24206941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Flavonoids in Neurodegenerative Diseases: Limitations and Future Perspectives.
    Maan G; Sikdar B; Kumar A; Shukla R; Mishra A
    Curr Top Med Chem; 2020; 20(13):1169-1194. PubMed ID: 32297582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine and neurodegenerative disorders: so close yet so far.
    Tosi G; Vandelli MA; Forni F; Ruozi B
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1041-4. PubMed ID: 25912814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond.
    Decker M
    Curr Med Chem; 2011; 18(10):1464-75. PubMed ID: 21428895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.